![Masayoshi Son (via Shutterstock/glen photo)](https://reaction.life/wp-content/uploads/2023/09/shutterstock_1431230738-600x375.jpg)
You cannot be serious, Son
Masayoshi Son’s Arm is touted as a $64bn stock. But a door-stopping document suggests Arm could be worth a great deal less when it comes to market value.
Masayoshi Son’s Arm is touted as a $64bn stock. But a door-stopping document suggests Arm could be worth a great deal less when it comes to market value.
Neil Collins’ Notebook: To understand why share prices are rising to all-time highs despite a looming recession, we have to look East.
Lucy speaks to Business Editor Martin Vander Weyer about why the recent high of the FTSE100 matters and how the voter might react to the recent Rishi-uffle.
From tech to energy, asset markets had a rollercoaster year.
Neil Collins’ Notebook: The GlaxoSmithKline separation has only served to make a small group of individuals at the top even richer.
Subscribe to Reaction and receive unlimited access to the site, our daily email with analysis every evening and invites to online events.
© Copyright 2024 Reaction Digital Media Limited – All Rights Reserved. Registered Company in England & Wales – Company Number: 10166531.